A. Onat And G. HERGENÇ, "Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk," METABOLISM-CLINICAL AND EXPERIMENTAL , vol.60, no.4, pp.499-512, 2011
Onat, A. And HERGENÇ, G. 2011. Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. METABOLISM-CLINICAL AND EXPERIMENTAL , vol.60, no.4 , 499-512.
Onat, A., & HERGENÇ, G., (2011). Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. METABOLISM-CLINICAL AND EXPERIMENTAL , vol.60, no.4, 499-512.
Onat, Altan, And Gülay HERGENÇ. "Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk," METABOLISM-CLINICAL AND EXPERIMENTAL , vol.60, no.4, 499-512, 2011
Onat, Altan And HERGENÇ, Gülay. "Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk." METABOLISM-CLINICAL AND EXPERIMENTAL , vol.60, no.4, pp.499-512, 2011
Onat, A. And HERGENÇ, G. (2011) . "Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk." METABOLISM-CLINICAL AND EXPERIMENTAL , vol.60, no.4, pp.499-512.
@article{article, author={Altan Onat And author={Gülay HERGENÇ}, title={Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk}, journal={METABOLISM-CLINICAL AND EXPERIMENTAL}, year=2011, pages={499-512} }